SerialBrain9 wrote on Jan 8
th, 2025 at 7:11pm:
Jasin wrote on Jan 8
th, 2025 at 6:37pm:
None of them are actual vaccines, more just immune boosters, hence why people had to get another shot after shot until their immune systems have become totally dependent on shots.
Exactly right - they are NOT vaccines… 💉
However…
They DESTROY your immune system and hence the turbo cancers, blood clots, myocarditis, heart attacks, strokes etc etc etc
yeah
a few vaccines are good but crikey they are pushing a lot nowadays
a highly interfered with immune system is a wierd way to promote health
check out all the vaccines your immune system is now expected to deal with
even more if you are aboriginal
Childhood vaccines
Age Disease Vaccine Information
Birth Hepatitis B H-B-Vax II (IM) or Engerix B (IM) Within 7 days of birth (ideally within 24 hours).
6 weeks Diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, polio Infanrix Hexa (IM) or Vaxelis (IM)
Pneumococcal Prevenar 13 (IM)
Rotavirus Rotarix (Oral) Dose 1 limited to 6-14 weeks of age.
Meningococcal B (Aboriginal1 children only) Bexsero (IM)
Prophylactic paracetamol recommended.
Recommended for other childhren - see the Australia Immunisation Handbook
4 months Diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, polio Infanrix Hexa (IM) or Vaxelis (IM)
Pneumococcal Prevenar 13 (IM)
Rotavirus Rotarix (Oral) Dose 2 limited to 10-24 weeks
Meningococcal B (Aboriginal children only) Bexsero (IM) Prophylactic paracetamol recommended.
Recommended for other childhren - see the Australia Immunisation Handbook
6 months Diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, polio Infanrix Hexa (IM) or Vaxelis (IM) Children ≥6 months with at risk conditions for invasive pneumococcal disease are recommended to receive an additional dose of Prevenar 13 – see the Australian Immunisation Handbook
Aboriginal children ≥6 months with certain at risk conditions may require an additional dose of Bexsero – see the Australian Immunisation Handbook
12 months Meningococcal ACWY Nimenrix (IM)
Pneumococcal Prevenar 13 (IM)
Measles, mumps, rubella MMR II or Priorix (IM or SC)
Meningococcal B (Aboriginal children only) Bexsero (IM) Prophylactic paracetamol recommended.
Recommended for other childhren - see the Australia Immunisation Handbook
18 months Diphtheria, tetanus, pertussis Infanrix or Tripacel (IM)
Measles, mumps, rubella, varicella Priorix Tetra (IM or SC)
Haemophilus influenzae type b ACT-HIB (IM or SC)
4 years Diphtheria, tetanus, pertussis, polio Infanrix-IPV (IM) or Quadracel (IM) Children with at risk conditions for invasive pneumococcal disease are recommended to receive an additional dose of Pneumovax 23 – see the Australian Immunisation Handbook
At risk groups, adolescents and adults
Age/Condition Disease Vaccine Information
All people with asplenia, hyposplenia, complement deficiency and treatment with eculizumab Meningococcal ACWY Nimenrix (IM) See the Australian Immunisation Handbook for required doses and timing.
Additional groups are recommended to receive these vaccines but these are not funded.
Meningococcal B Bexsero (IM)
>5 years with asplenia or hyposplenia Haemophilus influenzae type b ACT-HIB (IM or SC) If incompletely vaccinated or not vaccinated in childhood.
≥ 18 years Zoster Shingrix (IM) Eligible people ≥ 18 years considered at increased risk of herpes zoster due to an underlying condition and/or immunomodulatory/immunosuppressive treatments - see the Australian Immunisation Handbook
Year 7 Diphtheria, tetanus, pertussis Boostrix (IM) or Adacel (IM)
Human papillomavirus Gardasil 9 (IM)
Year 10 Meningococcal ACWY MenQuadfi (IM)
Pregnant Influenza
Influenza Any trimester.
Pertussis Boostrix or Adacel (IM) Each pregnancy between 20-32 weeks.
Aboriginal people
≥50 years Pneumococcal Prevenar 13 (IM) then Pneumovax23 (IM) Prevenar 13: ≥50 years.
Pneumovax 23: 2-12 months later.
Pneumovax 23: at least 5 years later (see the Australian Immunisation Handbook)
Zoster Shingrix (IM) Shingrix: ≥ 50 years.
≥65 years Zoster Shingrix (IM) Shingrix funded for people ≥65 years.
≥70 years Pneumococcal Prevenar 13 (IM) Pneumococcal funded for people ≥70.
People with at risk conditions for invasive pneumococcal disease See the Australian Immunisation Handbook for conditions recommended to receive Prevenar 13 and Pneumovax 23.
Influenza
Age/At risk condition Recommendation Information
All children 6 months <5 years Annual influenza vaccination Discuss influenza vaccination with other present family members.
Children aged less than 9 years of age who are receiving the influenza vaccine for the first time should receive 2 doses of the vaccine, 4 weeks apart.
For vaccine brands and eligibility see Seasonal influenza vaccination.
Aboriginal people ≥6 months
People with at risk conditions ≥6 months
≥65 years
Pregnant women